Please wait

Exhibit 107

Calculation of Filing Fee Tables

Form S-3

(Form Type)

Centessa Pharmaceuticals plc

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

                         
     Security
Type		  

Security

Class

Title

  

Fee

Calculation

or Carry

Forward

Rule

  

Amount

Registered

  

Proposed

Maximum

Offering
Price Per
Unit

  

Maximum

Aggregate

Offering

Price

  

Fee

Rate

  

Amount of

Registration
Fee

  

Carry

Forward

Form

Type

  

Carry

Forward
File

Number

  

Carry

Forward

Initial

effective
date

  

Filing Fee

Previously
Paid In
Connection

with
Unsold

Securities
to be

Carried

Forward

 
Newly Registered Securities
                         
Fees to Be Paid   Equity   Ordinary shares, nominal value £0.002 per share (2)   457(r)   17,542,372   $14.75   $258,749,987   0.0001476   $38,191.50          
                         
Fees Previously Paid   —    —   —   —   —   —     —          
 
Carry Forward Securities
                         
Carry Forward Securities   —    —   —   —     —       —   —   —    —
                   
    Total Offering Amounts      $258,749,987     $38,191.50          
                   
    Total Fees Previously Paid          —          
                   
    Total Fee Offsets          —          
                   
    Net Fee Due(1)                $38,191.50                

 

(1)

The filing fee, calculated in accordance with rule 457(r) under the Securities Act of 1933, has been transmitted to the Securities and Exchange Commission in connection with the securities offered by means of this prospectus supplement. This “Calculation of Filing Fee Tables” shall be deemed to update the “Calculation of Filing Fee Tables” in the registrant’s registration statement on form S-3ASR filed with the Securities and Exchange Commission on September 11, 2024 (333-282032)

(2)

A separate Registration Statement on Form F-6 for the registration of American Depositary Shares, each representing one ordinary share, issuable upon deposit of the ordinary shares registered hereby was previously filed with the Securities and Exchange Commission and was effective on May 27, 2021 (Registration No. 333-256385).